Add the following:
Pyrantel Tartrate
(pi ran' tel tar' trate).
Click to View Image

C11H14N2S·C4H6O6
356.39
Pyrimidine, 1,4,5,6-tetrahydro-1-methyl-2-[2-(2-thienyl)ethenyl]-, (E)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1);    

(E)-1,4,5,6-Tetrahydro-1-methyl-2-[2-(2-thienyl)vinyl]pyrimidine tartrate (1:1)    
[33401-94-4].
DEFINITION
Pyrantel Tartrate contains NLT 98.0% and NMT 102.0% of pyrantel tartrate (C11H14N2S·C4H6O6), calculated on the dried basis.
IDENTIFICATION
•  A. Infrared Absorption 197K
[Note—Concomitantly prepare potassium bromide dispersions of the Standard and sample. Differences between sets of Standard/sample spectra may occur as a result of differing specimen preparation or environmental conditions. ]
•  C. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
ASSAY
•  Procedure
[Note—Protect all solutions containing Pyrantel Tartrate from light. ]
Mobile phase:  Acetonitrile, glacial acetic acid, diethylamine, and water (94: 2.5: 1: 2.5)
Standard solution:  0.42 mg/mL of USP Pyrantel Tartrate RS in Mobile phase
Sample solution:  0.42 mg/mL of Pyrantel Tartrate in Mobile phase
Chromatographic system 
Mode:  LC
Detector:  UV 316 nm
Column:  4.6-mm × 25-cm; 5-µm packing L3
Flow rate:  1 mL/min
Injection volume:  5 µL
System suitability 
Sample:  Standard solution
Suitability requirements 
Tailing factor:  NMT 1.5
Relative standard deviation:  NMT 0.73%
Analysis 
Samples:  Standard solution and Sample solution
Calculate the percentage of pyrantel tartrate (C11H14N2S·C4H6O6) in the portion of Pyrantel Tartrate taken:
Result = (rU/rS) × (CS/CU) × 100

rU== peak response from the Sample solution
rS== peak response from the Standard solution
CS== concentration of USP Pyrantel Tartrate RS in the Standard solution (mg/mL)
CU== concentration of Pyrantel Tartrate in the Sample solution (mg/mL)
Acceptance criteria:  98.0%–102.0% on the dried basis
IMPURITIES
•  Residue on Ignition 281: NMT 0.1%
•  Organic Impurities
[Note—Protect all solutions containing Pyrantel Tartrate from light. ]
Mobile phase:  Acetonitrile, glacial acetic acid, diethylamine, and water (94: 2.5: 1: 2.5)
Standard solution:  0.84 µg/mL of USP Pyrantel Tartrate RS in Mobile phase
Sample solution:  0.42 mg/mL of Pyrantel Tartrate in Mobile phase
System suitability solution:  Expose a portion of the Sample solution to short-wavelength UV light for 30 min (Pyrantel Tartrate undergoes partial degradation to cis-pyrantel). A degradation level to at least 0.3% of cis-pyrantel must be obtained, as shown by the appearance of a corresponding peak in the chromatogram. If it is not obtained, again expose the solution to short-wavelength UV light.
Chromatographic system 
Mode:  LC
Detector:  UV 236 and 316 nm
Column:  4.6-mm × 25-cm; 5-µm packing L3
Flow rate:  1 mL/min
Run time:  2.5 times the retention time of pyrantel
Injection volume:  100 µL
System suitability 
Sample:  System suitability solution
[Note—The relative retention times for pyrantel and cis-pyrantel are 1.0 and 1.2, respectively. ]
Suitability requirements 
System suitability requirements must be met at both 236 and 316 nm.
Resolution:  NLT 1.5 between pyrantel and cis-pyrantel
Analysis 
Samples:  Standard solution and Sample solution
Calculate the percentage of each impurity detected at 236 nm in the portion of Pyrantel Tartrate taken:
Result = (rU/rS) × (CS/CU) × 100

rU== peak response of each individual impurity detected at 236 nm from the Sample solution
rS== peak response detected at 236 nm from the Standard solution
CS== concentration of the Standard solution (mg/mL)
CU== concentration of the Sample solution (mg/mL)
Calculate the percentage of each impurity detected at 316 nm in the portion of Pyrantel Tartrate taken:
Result = (rU/rS) × (CS/CU) × 100

rU== peak response of each individual impurity detected at 316 nm from the Sample solution
rS== peak response detected at 316 nm from the Standard solution
CS== concentration of the Standard solution (mg/mL)
CU== concentration of the Sample solution (mg/mL)
Acceptance criteria 
Any individual impurity:  NMT 0.2% of any individual impurity detected at 236 nm; NMT 0.2% of any individual impurity detected at 316 nm
Total impurities:  NMT 1.0% of total impurities detected at 236 nm; NMT 1.0% of total impurities detected at 316 nm
SPECIFIC TESTS
•  pH 791
Sample solution:  10.0 mg/mL in carbon dioxide-free water
Acceptance criteria:  3.3–3.7
•  Loss on Drying 731
Analysis:  Dry at 105 for 4 h.
Acceptance criteria:  NMT 1.0%
ADDITIONAL REQUIREMENTS
•  Packaging and Storage: Preserve in well-closed containers protected from light, and store at room temperature.
•  Labeling: Label it to indicate that it is for veterinary use only.
•  USP Reference Standards 11
USP Pyrantel Tartrate RS Click to View Structure
USP38
Auxiliary Information— Please check for your question in the FAQs before contacting USP.
Topic/Question Contact Expert Committee
Monograph Morgan Puderbaugh
Scientific Liaison
(301) 998-6833
(SM32010) Monographs - Small Molecules 3
Reference Standards RS Technical Services
1-301-816-8129
rstech@usp.org
USP38–NF33 Page 5087
Pharmacopeial Forum: Volume No. 40(1)